Blueprint Medicines Corporation
Latest round
- Series C
Last raised
- Nov 2014
Total raised
- $113M
Investors
- 13
About Blueprint Medicines Corporation
Blueprint Medicines Corporation, founded in 2011, is headquartered in Cambridge, US. The company specializes in targeted therapies for rare diseases. Its founder, Alexis Borisy, has a history of founding other companies in the biopharmaceutical sector.Blueprint Medicines Corporation specializes in developing targeted therapies for patients with rare diseases, focusing on mast cell disorders and specific cancers. Their flagship product, AYVAKIT® (avapritinib), is approved for treating indolent and advanced systemic mastocytosis and unresectable or metastatic gastrointestinal stromal tumors with specific mutations.38 mn. The company generates revenue through sales of its proprietary therapies, with a focus on direct sales to healthcare providers. Their revenue structure ensures that patients have access to innovative treatments through individual prescriptions and partnerships with pharmaceutical distributors and healthcare organizations. As part of its growth strategy, the company is focusing on the launch of upcoming products and expanding its market reach into new geographic regions. Specific target markets and timelines for these initiatives are not detailed but are aligned with the company’s commitment to addressing unmet medical needs.
Who invested in Blueprint Medicines Corporation
13 investors across 5 rounds
See all investors in Blueprint Medicines Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Blueprint Medicines Corporation
Who invested in Blueprint Medicines Corporation?
Blueprint Medicines Corporation has 13 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Blueprint Medicines Corporation raised?
Blueprint Medicines Corporation has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Blueprint Medicines Corporation last raise money?
Blueprint Medicines Corporation's most recent round on record is a Series C, in Nov 2014.
What does Blueprint Medicines Corporation do?
Blueprint Medicines Corporation, founded in 2011, is headquartered in Cambridge, US.
Where is Blueprint Medicines Corporation headquartered?
Blueprint Medicines Corporation is headquartered in Cambridge, US.
Which VCs invest in companies like Blueprint Medicines Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Blueprint Medicines Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Blueprint Medicines Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.